Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer

نویسندگان

  • Bo Gao
  • Amanda Russell
  • Jonathan Beesley
  • Xiao Qing Chen
  • Sue Healey
  • Michelle Henderson
  • Mark Wong
  • Catherine Emmanuel
  • Laura Galletta
  • Sharon E. Johnatty
  • David Bowtell
  • David Bowtell
  • Georgia Chenevix-Trench
  • Anna deFazio
  • Dorota Gertig
  • Adle Green
  • Penelope Webb
  • Jillian Hung
  • Sue Moore
  • Nadia Traficante
  • Sian Fereday
  • Karen Harrap
  • Troy Sadkowsky
  • Nirmala Pandeya
  • Robin Stuart-Harris
  • Fred Kirsten
  • Josie Rutovitz
  • Peter Clingan
  • Amanda Glasgow
  • Anthony Proietto
  • Stephen Braye
  • Greg Otton
  • Jennifer Shannon
  • Tony Bonaventura
  • James Stewart
  • Stephen Begbie
  • Michael Friedlander
  • David Bell
  • Sally Baron-Hay
  • Alan Ferrier
  • Greg Gard
  • David Nevell
  • Nick Pavlakis
  • Sue Valmadre
  • Barbara Young
  • Catherine Camaris
  • Roger Crouch
  • Lyndal Edwards
  • Neville Hacker
  • Donald Marsden
  • Greg Robertson
  • Phillip Beale
  • Jane Beith
  • Jonothan Carter
  • Chris Dalrymple
  • Anne Hamilton
  • Roger Houghton
  • Peter Russell
  • Matthew Links
  • John Grygiel
  • Jane Hill
  • Alison Brand
  • Karen Byth
  • Richard Jaworski
  • Paul Harnett
  • Raghwa Sharma
  • Anita Achen
  • Gerard Wain
  • Bruce Ward
  • David Papadimos
  • Alex Crandon
  • Margaret Cummings
  • Ken Horwood
  • Andreas Obermair
  • Lew Perrin
  • David Wyld
  • Jim Nicklin
  • Margaret Davy
  • Martin K Oehler
  • Chris Hall
  • Tom Dodd
  • Tabitha Healy
  • Ken Pittman
  • Doug Henderson
  • John Miller
  • John Pierdes
  • Penny Blomfield
  • David Challis
  • Robert McIntosh
  • Andrew Parker
  • Bob Brown
  • Robert Rome
  • David Allen
  • Peter Grant
  • Simon Hyde
  • Rohan Laurie
  • Melissa Robbie
  • David Healy
  • Tom Jobling
  • Tom Manolitsas
  • Jane McNealage
  • Peter Rogers
  • Beatrice Susil
  • Eric Sumithran
  • Ian Simpson
  • Kelly Phillips
  • Danny Rischin
  • Stephen Fox
  • Daryl Johnson
  • Paul Waring
  • Stephen Lade
  • Maurice Loughrey
  • Neil O’Callaghan
  • William Murray
  • Virginia Billson
  • Jan Pyman
  • Debra Neesham
  • Michael Quinn
  • Craig Underhill
  • Richard Bell
  • Leong-Fook Ng
  • Robert Blum
  • Vinod Ganju
  • Ian Hammond
  • Yee Leung
  • Anthony McCartney
  • Martin Buck
  • Izak Haviv
  • David Purdie
  • David Whiteman
  • Nikolajs Zeps
  • Mary-Rose Malt
  • Anne Mellon
  • Randall Robertson
  • Trish Vanden Bergh
  • Marian Jones
  • Patricia Mackenzie
  • Jane Maidens
  • Kath Nattress
  • Yoke-Eng Chiew
  • Annie Stenlake
  • Helen Sullivan
  • Barbara Alexander
  • Pat Ashover
  • Sue Brown
  • Tracy Corrish
  • Lyn Green
  • Leah Jackman
  • Kaltin Ferguson
  • Karen Martin
  • Adam Martyn
  • Barbara Ranieri
  • Jo White
  • Victoria Jayde
  • Leanne Bowes
  • Pamela Mamers
  • Laura Galletta
  • Debra Giles
  • Joy Hendley
  • Katherine Alsop
  • Trudy Schmidt
  • Helen Shirley
  • Colleen Ball
  • Cherry Young
  • Suzanna Viduka
  • Hoa Tran
  • Sanela Bilic
  • Lydia Glavinas
  • Julia Brooks
  • Michelle Haber
  • Murray Norris
  • Paul Harnett
  • Georgia Chenevix-Trench
  • Rosemary L. Balleine
  • Anna deFazio
چکیده

ABCB1 (adenosine triphosphate-binding cassette transporter B1) mediates cellular elimination of many chemotherapeutic agents including paclitaxel, which is commonly used to treat ovarian cancer. A significant association between common single nucleotide polymorphisms (SNPs) in ABCB1 and progression-free survival has been reported in patients with ovarian cancer. Variable paclitaxel clearance due to genotype specific differences in ABCB1 activity in cancer cells and/or normal tissues may underlie the association. Using cell-based models, we evaluated the correlations between ABCB1 expression, polymorphisms, transporter activity and paclitaxel sensitivity in ovarian cancer (n = 10) and lymphoblastoid (n = 19) cell lines. Close associations between ABCB1 expression, transporter function and paclitaxel sensitivity were found in lymphoblastoid cell lines, although we could not demonstrate an association with common SNPs. In ovarian cancer cell lines, ABCB1 expression was low and the association between expression and function was lost. These results suggest that ABCB1 related survival difference in ovarian cancer patients is more likely to be due to differential whole body paclitaxel clearance mediated by normal cells rather than a direct effect on cancer cells.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line

Objective(s): Multidrug resistance (MDR) is a major obstacle in the successful chemotherapy of ovarian cancer. Inhibition of P-glycoprotein (P-gp), a member of ATP-binding cassette (ABC) transporters, is a well-known strategy to overcome MDR in cancer. The aim of this study was to investigate the efficiency and ability of CRISPR/Cas9 genome editing technology to knockdown ABCB1 gene expression ...

متن کامل

Johnatty, S. E. et al. (2013) ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome

☆ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited. • ABCB1 C1236T (rs1128503) was marginally associated with improved overall survival in 4,616 invasive ovarian cancer patien...

متن کامل

Association between ABCB1-T1236C Polymorphism and Drug-Resistant Epilepsy in Iranian Female Patients

Background: One third of epileptic patients are resistant to several anti-epileptic drugs (AED). P-glycoprotein (P-gp) is an efflux transporter encoded by ATP-binding cassette subfamily B member 1 (ABCB1) gene that excludes drugs from the cells and plays a significant role in AEDs resistance. Over-expression of P-gp could be a result of polymorphisms in ABCB1 gene. We studied the association of...

متن کامل

Targeting multidrug-resistant ovarian cancer through estrogen receptor α dependent ATP depletion caused by hyperactivation of the unfolded protein response

Ovarian cancers often recur and tumors acquire resistance to chemotherapy due to overexpression of the ATP-dependent efflux pump, multidrug resistance protein 1 (MDR1/P-glycoprotein/ABCB1). Nontoxic small molecule inhibitors targeting MDR1 have remained largely elusive. Instead, in a novel application of our recently described estrogen receptor α (ERα) biomodulator, BHPI, we targeted MDR1's sub...

متن کامل

ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel.

P-glycoprotein (P-gp), encoded by the ABCB1 gene, confers multi-drug resistance to a variety of antineoplastic agents, for example, paclitaxel. Recently, the G1199T/A polymorphism in the ABCB1 gene was shown to be important for the function of P-gp as well as for the resistance to several chemotherapeutic agents in vitro. We analyzed the allelic distribution of the G1199T/A and other polymorphi...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 4  شماره 

صفحات  -

تاریخ انتشار 2014